Statements (33)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
recreational drug |
gptkbp:ATCCode |
none
|
gptkbp:CASNumber |
2759-28-6
|
gptkbp:chemicalFormula |
C11H16N2
|
gptkbp:discoveredBy |
1944
|
gptkbp:effect |
stimulant
euphoriant |
gptkbp:excretion |
kidneys
|
gptkbp:hasInChIKey |
VQINNJQOEPYTFE-UHFFFAOYSA-N
|
gptkbp:hasSMILES |
c1ccc(cc1)CN2CCNCC2
|
https://www.w3.org/2000/01/rdf-schema#label |
1-benzylpiperazine
|
gptkbp:IUPACName |
gptkb:1-benzylpiperazine
|
gptkbp:legalStatus |
illegal in many countries
|
gptkbp:meltingPoint |
145–147 °C (free base)
236–237 °C (hydrochloride salt) |
gptkbp:metabolism |
liver
|
gptkbp:molecularWeight |
176.26 g/mol
|
gptkbp:relatedTo |
gptkb:piperazine
gptkb:MDMA |
gptkbp:routeOfAdministration |
oral
insufflation |
gptkbp:sideEffect |
nausea
anxiety headache insomnia palpitations |
gptkbp:synonym |
gptkb:benzylpiperazine
gptkb:BZP |
gptkbp:UNII |
6Z5B6HVF6O
|
gptkbp:usedFor |
party pill
|
gptkbp:bfsParent |
gptkb:BZP
|
gptkbp:bfsLayer |
7
|